US Congress Senate Bill 3013 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on December 10 2019 - 25% progression, died in committee
Action: 2019-12-10 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Allows prescription drug plan (PDP) sponsors under the Medicare prescription drug benefit to offer additional plans in a region. Specifically, the Centers for Medicare & Medicaid Services (CMS) must update guidance to allow PDP sponsors to offer up to four plans in a region; the CMS may also set a greater limit, as appropriate. PDP sponsors may offer up to two additional plans beyond this limit if the PDP sponsor ensures that, under at least one of the plans, pharmacy benefit managers do not receive any remuneration unless at least 10% of price reductions received from drug manufacturers are reflected at the point-of-sale or otherwise used to reduce beneficiary cost-sharing.

Encouraging Innovative Benefit Design to Lower Costs for Seniors Act

Sen. Pat Toomey [R-PA]

Sen. Mike Crapo [R-ID]

Sen. John Kennedy [R-LA]

Date	Chamber	Action
2019-12-10	Senate	Read twice and referred to the Committee on Finance.

HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/senate-bill/3013/all-info
Text	https://www.congress.gov/116/bills/s3013/BILLS-116s3013is.pdf